PHOTOPHERESIS PRODUCTS MARKET ANALYSIS
Photopheresis Products Market - Regional Insights
On the basis of region, the global photopheresis products market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global photopheresis products market as its government provides the reimbursements for various treatments like GVHD, cytotoxic T-lymphocytes and lung transplantation treated by ECP therapy are the factors accountable for growth of the market. According to Leukemia and Lymphoma society, in 2017, 30-70% people suffer from cGVHD. Moreover, frequent approvals by regulatory bodies by European commission for photophoresis products are expected to drive the market. For instance, in August 2016, Swiss regulators approved the reimbursement of Mallinckrodt plc.’s ECP treatment for patients suffering from bronchiolitis obliterans syndrome (BOS), following a lung transplant.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
